BridgeBio Pharma BBIO Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $882.02M+417% | $170.49M-73.6% | $645.1M-13.9% | $748.95M+38.0% | $542.74M-20.6% | ||
| $60.3M+247% | $17.36M+481% | $2.99M-62.3% | $7.94M— | —— | ||
| $205.23M+47.2% | $139.44M+19.7% | $116.52M+51.6% | $76.87M-33.3% | $115.27M+2,341% | ||
| $32.98M+23.3% | $26.75M+9.1% | $24.53M+34.2% | $18.28M+362% | $3.95M— | ||
| $1.24B+55.6% | $797.75M-5.0% | $839.38M-8.0% | $912.28M+31.2% | $695.17M-3.5% | ||
| $4.94M-7.9% | $5.37M-8.0% | $5.83M-4.5% | $6.11M-8.8% | $6.7M-4.5% | ||
| $27.36M-2.6% | $28.08M-2.5% | $28.8M-2.4% | $29.51M+6.2% | $27.8M+16.2% | ||
| $1.37B+46.5% | $936.03M-6.2% | $998.25M-7.6% | $1.08B+22.5% | $881.64M-4.1% | ||
| $29.06M-19.8% | $36.23M+93.7% | $18.7M-28.4% | $26.13M-5.1% | $27.53M+186% | ||
| $6.12M-15.0% | $7.19M-20.9% | $9.09M-38.0% | $14.67M-16.2% | $17.51M+19.9% | ||
| $588.5M— | —— | $40.63M— | —— | —— | ||
| $816.37M+183% | $287.97M+33.0% | $216.6M+23.2% | $175.85M+15.6% | $152.11M-1.5% | ||
| $2.65B— | —— | $2.01B— | $0— | $0-100% | ||
| $3.64B+20.8% | $3.01B+3.1% | $2.92B+2.2% | $2.86B+13.4% | $2.52B+6.0% | ||
| 500M0.0% | 500M0.0% | 500M+252,425% | 198K+0.5% | 197K+0.5% | ||
| -$3.99B-4.3% | -$3.82B-5.3% | -$3.63B-5.3% | -$3.45B-5.6% | -$3.26B-5.4% | ||
| -$2.28B-9.2% | -$2.09B-7.9% | -$1.93B-8.1% | -$1.79B-8.5% | -$1.65B-12.3% | ||
| $1.37B+46.5% | $936.03M-6.2% | $998.25M-7.6% | $1.08B+22.5% | $881.64M-4.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are BridgeBio Pharma's total assets?
- BridgeBio Pharma (BBIO) holds $1.4B in total assets, up 55.5% year over year.
- How much debt does BridgeBio Pharma have?
- BridgeBio Pharma carries $3.3B in total debt against -$2.3B of shareholders' equity, a debt-to-equity ratio of 1.97.
- How much cash does BridgeBio Pharma have?
- BridgeBio Pharma holds $882.0M in cash and equivalents.
- Can BridgeBio Pharma cover its short-term obligations?
- Its current ratio is 1.52 — current assets exceed current liabilities.
- Where does BridgeBio Pharma's balance sheet data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
